Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation.
Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation.
复制标题
DOI:
10.1016/j.neuron.2015.06.007
复制
发表时间:
2015-07-15
期刊:
影响因子:
16.2
通讯作者:
Woolf CJ
中科院分区:
文献类型:
--
作者:
Talbot S;Abdulnour RE;Burkett PR;Lee S;Cronin SJ;Pascal MA;Laedermann C;Foster SL;Tran JV;Lai N;Chiu IM;Ghasemlou N;DiBiase M;Roberson D;Von Hehn C;Agac B;Haworth O;Seki H;Penninger JM;Kuchroo VK;Bean BP;Levy BD;Woolf CJ
Lung nociceptors initiate cough and bronchoconstriction. To elucidate if these fibers also contribute to allergic airway inflammation we stimulated lung nociceptors with capsaicin and observed increased neuropeptide release and immune cell infiltration. In contrast, ablating Nav1.8+ sensory neurons or silencing them with QX-314, a charged sodium channel inhibitor that enters via large pore ion channels to specifically block nociceptors, substantially reduced ovalbumin or house dust mite-induced airway inflammation and bronchial hyperresponsiveness. We also discovered that IL-5, a cytokine produced by activated immune cells, acts directly on nociceptors to induce release of vasoactive intestinal peptide (VIP). VIP then stimulates CD4+ and resident innate lymphoid type 2 cells, creating an inflammatory signaling loop that promotes allergic inflammation. Our results indicate that nociceptors amplify pathological adaptive immune responses and that silencing these neurons with QX-314 interrupts this neuro-immune interplay, revealing a potential new therapeutic strategy for asthma.